Acyclovir - 55390-613-20 - (Acyclovir sodium)

Alphabetical Index


Drug Information of Acyclovir

Product NDC: 55390-613
Proprietary Name: Acyclovir
Non Proprietary Name: Acyclovir sodium
Active Ingredient(s): 1000    mg/20mL & nbsp;   Acyclovir sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Acyclovir

Product NDC: 55390-613
Labeler Name: Bedford Laboratories
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074596
Marketing Category: ANDA
Start Marketing Date: 19970423

Package Information of Acyclovir

Package NDC: 55390-613-20
Package Description: 10 VIAL in 1 BOX (55390-613-20) > 20 mL in 1 VIAL

NDC Information of Acyclovir

NDC Code 55390-613-20
Proprietary Name Acyclovir
Package Description 10 VIAL in 1 BOX (55390-613-20) > 20 mL in 1 VIAL
Product NDC 55390-613
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Acyclovir sodium
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19970423
Marketing Category Name ANDA
Labeler Name Bedford Laboratories
Substance Name ACYCLOVIR SODIUM
Strength Number 1000
Strength Unit mg/20mL
Pharmaceutical Classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient]

Complete Information of Acyclovir


General Information